Locoregional therapy in luminal-like and HER2-enriched patients with de novo stage IV breast cancer

BACKGROUND: Locoregional therapy is rarely the standard of care for De Novo stage IV breast cancer but usually used for palliation of symptoms. This retrospective study aimed to determine whether surgery or radiation would contribute to survival benefit for this group of patients by examining the su...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Peng-Yu, Cheng, Skye Hung-Chun, Hung, Chen-Fang, Yu, Ben-Long, Chen, Chii-Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2013
Materias:
Database
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4320159/
https://www.ncbi.nlm.nih.gov/pubmed/25674416
http://dx.doi.org/10.1186/2193-1801-2-589

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4320159/
https://www.ncbi.nlm.nih.gov/pubmed/25674416
http://dx.doi.org/10.1186/2193-1801-2-589

Ejemplares similares